- Home
- ISPR vs KIO Comparison
ISPR vs KIO Comparison
Compare ISPR & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- KIO
- Stock Information
- Founded
- ISPR 2019
- KIO 2011
- Country
- ISPR United States
- KIO United States
- Employees
- ISPR N/A
- KIO 2400
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- KIO Investment Managers
- Sector
- ISPR Health Care
- KIO Finance
- Exchange
- ISPR Nasdaq
- KIO Nasdaq
- Market Cap
- ISPR 427.6M
- KIO 392.2M
- IPO Year
- ISPR 2023
- KIO N/A
- Fundamental
- Price
- ISPR $6.25
- KIO $14.79
- Analyst Decision
- ISPR Strong Buy
- KIO
- Analyst Count
- ISPR 1
- KIO 0
- Target Price
- ISPR $12.50
- KIO N/A
- AVG Volume (30 Days)
- ISPR 187.5K
- KIO 136.5K
- Earning Date
- ISPR 11-11-2024
- KIO 01-01-0001
- Dividend Yield
- ISPR N/A
- KIO 10.82%
- EPS Growth
- ISPR N/A
- KIO N/A
- EPS
- ISPR N/A
- KIO N/A
- Revenue
- ISPR $151,908,691.00
- KIO N/A
- Revenue This Year
- ISPR $44.59
- KIO N/A
- Revenue Next Year
- ISPR N/A
- KIO N/A
- P/E Ratio
- ISPR N/A
- KIO N/A
- Revenue Growth
- ISPR 31.40
- KIO N/A
- 52 Week Low
- ISPR $5.01
- KIO $10.52
- 52 Week High
- ISPR $19.78
- KIO $13.59
- Technical
- Relative Strength Index (RSI)
- ISPR 39.80
- KIO 60.82
- Support Level
- ISPR $6.21
- KIO $14.66
- Resistance Level
- ISPR $6.50
- KIO $14.81
- Average True Range (ATR)
- ISPR 0.48
- KIO 0.13
- MACD
- ISPR -0.06
- KIO -0.01
- Stochastic Oscillator
- ISPR 24.51
- KIO 78.26
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.